Pro-inflammatory chemokines, such as chemokine C-X-C motif ligand 12 (CXCL12) and high mobility group box 1 (HMGB1) [89,90] are increased in EB patients [91], sometimes in correlation with the affected body surface area [91]. This evidence concerns the gene CXCL12 and epidermolysis bullosa.